<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7367788\results\search\drug\results.xml">
  <result pre="with standard treatment regimen. Various antineoplastic drugs (etoposide, methotrexate, melphalan," exact="isotretinoin" post="plus tamoxifen, nintedanib, lenalidomide, etc.) and drugs like thalidomide,"/>
  <result pre="like thalidomide, oxytocin, chlorpromazine, montelukast, povidone-iodine, famotidine, cholecalciferol, N-acetylcysteine, and" exact="pyridostigmine" post="bromide have also been studied in clinical trials for"/>
  <result pre="respiratory distress associated with COVID-19, the role of drugs like" exact="valsartan" post="and sirolimus is being investigated in various clinical trials."/>
  <result pre="associated with COVID-19, the role of drugs like valsartan and" exact="sirolimus" post="is being investigated in various clinical trials. There is"/>
  <result pre="action for use in COVID-19 Disease indication (Approved/Investigational)* Remdesivir (antiviral," exact="adenosine" post="nucleotide analog) Phase 2/3 Target RdRp and inhibit it,"/>
  <result pre="inhibits viral RNA synthesis Approved to treat influenza in Japan" exact="Ribavirin" post="(antiviral, guanine nucleotide analog) Phase 1/2 Target RdRp and"/>
  <result pre="mRNA capping Chronic hepatitis C virus (HCV) infection Galidesivir (antiviral," exact="adenosine" post="nucleoside analog) Phase 1 Target and bind to viral"/>
  <result pre="maturation Approved for HIV-1 infection Darunavir (antiviral, protease inhibitor) and" exact="Cobicistat" post="(Pharmacokinetic enhancer) Phase 1 Target protease enzyme, inhibits protein"/>
  <result pre="viral DNA into the nucleus Investigational drug for hepatitis B" exact="Chloroquine" post="and hydroxychloroquine (antimalarial, aminoquinolone derivative, antiviral and immunomodulatory properties)"/>
  <result pre="into the nucleus Investigational drug for hepatitis B Chloroquine and" exact="hydroxychloroquine" post="(antimalarial, aminoquinolone derivative, antiviral and immunomodulatory properties) Phase 2/3/4"/>
  <result pre="of cytokines and growth factors Rheumatoid arthritis in adult patients" exact="Ruxolitinib" post="(kinase inhibitor) Phase 1/2/3 Target JAK kinase receptor, JAK"/>
  <result pre="cascades of cytokines and growth factors Intermediate or high-risk myelofibrosis" exact="Acalabrutinib" post="(kinase inhibitor) Phase 2 A selective inhibitor of Brutonâ€™s"/>
  <result pre="a protein encoded by SARS-CoV-2 genes Severe recalcitrant nodular acne" exact="Naproxen" post="(anti-inflammatory) (studied in combination with antiviral) Phase 3 Inhibit"/>
  <result pre="gouty arthritis, primary dysmenorrhea, for inflammation and pain in musculoskeletal" exact="Azithromycin" post="(broad-spectrum macrolide antibiotic (studied alone or in combination with"/>
  <result pre="Azithromycin (broad-spectrum macrolide antibiotic (studied alone or in combination with" exact="hydroxychloroquine" post="or amoxicillin/clavulanic acid)) Phase 2/3/4 Target bacterial ribosomes, inhibits"/>
  <result pre="and IL-6, prevents cytokine storm Gout and familial Mediterranean fever" exact="Deferoxamine" post="(iron chelator) Phase 1/2/3 Manages excess iron levels in"/>
  <result pre="of clot formation in indwelling intravenous lines for hemodialysis Inhaled" exact="nitric oxide" post="(INO) (pulmonary vasodilator) Phase 1/2 Targets heme molecule of"/>
  <result pre="Directions Antiviral Drugs Remdesivir (GS-5734) It is an investigational nucleotide" exact="adenosine" post="analog developed by Gilead Sciences, USA, and is a"/>
  <result pre="drugâ€&quot;drug interactions among individuals of a different region. Lopinavir and" exact="Ritonavir" post="These protease inhibitors are widely used for human immunodeficiency"/>
  <result pre="required to conclude the efficacy of LPV/RTV in COVID-19 patients." exact="Chloroquine" post="and Hydroxychloroquine They are amino-quinolines known for their anti-malarial"/>
  <result pre="conclude the efficacy of LPV/RTV in COVID-19 patients. Chloroquine and" exact="Hydroxychloroquine" post="They are amino-quinolines known for their anti-malarial and immunomodulatory"/>
  <result pre="established as a wide spectrum antiviral drug [36, 37]. Recently," exact="chloroquine" post="has demonstrated the efficacy against SARS-CoV-2 in Vero E6"/>
  <result pre="receiving standard supportive care. The authors also reported that including" exact="azithromycin" post="with HCQ for the treatment of 6 patients has"/>
  <result pre="based on their structural moiety, classical example being emetine, and" exact="quinine" post="[74]. WHO also supports and welcomes innovations around the"/>
  <result pre="such as Nigella sativa, natural honey, artemisinin, curcumin, Boswellia, and" exact="vitamin C" post="are in a clinical trial for COVID-19 [13]. Although"/>
  <result pre="a highly divergent RNA dependent RNA polymeraseAntivir Res2019169110 19.WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus ( 2019-nCoV"/>
  <result pre="al. Triple combination of interferon beta-1b , lopinavirâ€&quot;ritonavir , and" exact="ribavirin" post="in the treatment of patients admitted to hospital with"/>
  <result pre="into the antiviral effects of chloroquineLancet Infect Dis20066676916439323 37.YanYZouZSunYLiXXuKFWeiYJinNJiangCAnti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
  <result pre="potent inhibitor of SARS coronavirus infection and spreadVirol J2005211015631631 39.GaoJTianZYangXBreakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="Parola P, Hoang VT, Meddeb L, Mailhe M, et al." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVID-19: results of"/>
  <result pre="Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-"/>
  <result pre="J Antimicrob Agents. 2020. 10.1016/j.ijantimicag.2020.105949. 41.JunCHENDanpingLIULiLIUPingLIUQingnianXULXet al.A pilot study of" exact="hydroxychloroquine" post="in treatment of patients with moderate COVID-19Zhejiang Da Xue"/>
  <result pre="Z, Han M, Wang Z, Chen J SW et al." exact="Hydroxychloroquine" post="in patients mainly with mild to moderate COVIDâ€&quot;19: an"/>
  <result pre="Sampaio VS, Alexandre MAA, Melo GC, Brito M, et al." exact="Chloroquine" post="diphosphate in two different dosages as adjunctive therapy of"/>
  <result pre="2020;10.1101/2020.04.07.20056424. 44.Mehra MR, Desai SS, Ruschitzka F, Patel AN. Articles" exact="Hydroxychloroquine" post="or chloroquine with or without a macrolide for treatment"/>
  <result pre="MR, Desai SS, Ruschitzka F, Patel AN. Articles Hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
 </snippets>
</snippetsTree>
